Project Grant R01EY035319

Award Date 9/1/24
Completion Date 5/31/29
Dollars Obligated $441K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports research to optimize C-Met signaling to enhance corneal epithelial homeostasis. The $176,550 award to the University of Louisville aims to determine if inhibiting the negative regulation of the C-Met receptor can prolong its activity and accelerate corneal wound healing. The research will be conducted through in vitro experiments on corneal epithelial cells and in vivo studies using mouse corneal...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the human eye. The $543,037 award, effective September 1, 2024 through May 31, 2028, will fund investigations into the genetic and molecular mechanisms underlying corneal development and function. Key research objectives include identifying transcription factors and...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 - Vision Research) in the amount of $753,189 to Trustees of Boston University, doing business as Boston University Medical Campus, with a period of performance from August 1, 2024 to May 31, 2029. The grant will support research to identify novel therapeutic targets for corneal epithelial defects by revealing the differential roles of basal epithelial cells in the central cornea, limbus, and conjunctiva in corneal health and...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research grant program (CFDA 93.867), aims to develop a new high-resolution imaging technique for the human cornea. The objective is to create a system that can provide wide-field, three-dimensional, and polarization-sensitive imaging of fine corneal structures, overcoming limitations of current clinical imaging methods. The $237,996 award, effective February 1, 2025 through January 31, 2027, will support...
The National Eye Institute (NEI) awarded a $412,285 Project Grant under the Vision Research program (CFDA 93.867) to Oregon Health & Science University (OHSU) to validate an advanced transepithelial corneal collagen crosslinking (CXL) technology. The goal is to develop a more effective CXL procedure that can strengthen the cornea without requiring removal of the surface epithelium, which often leads to complications. The key products and services to be delivered include: Constructing an...
The National Eye Institute (NEI) awarded a $1,426,622 Project Grant under the Vision Research federal grant program (CFDA 93.867) to The Washington University in St. Louis to conduct research on the neural mechanisms underlying corneal injuries caused by ammonia exposure. The key objectives of this 4-year project are to: 1) correlate delayed corneal wound healing with ammonia-induced corneal nerve degeneration and associated ocular pain in mouse models; 2) characterize the sensitivity and...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to investigate the role of the Optineurin (OPTN) gene in Herpes Simplex Virus Type-1 (HSV-1) infection and its impact on corneal health and sensory nerve function. The $637,333 award to the University of Illinois aims to comprehensively study the molecular mechanisms by which OPTN regulates viral degradation, antigen presentation, and the innate-adaptive...
This Project Grant award of $2,174,069 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to elucidate the regenerative potential of the corneal endothelium and develop innovative mRNA-based therapies for Fuchs' Endothelial Corneal Dystrophy (FECD). The primary awardee, the University of Pennsylvania, will utilize advanced imaging, genetic mouse models, and mRNA technology to investigate CEC proliferation and signaling pathways, with the...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to develop a novel, laser-based approach for non-viral corneal gene delivery. The $431,750 award to the University of California, Irvine aims to create microscale channels through the corneal epithelium to enhance transepithelial diffusion, and use femtosecond laser pulses to permeabilize stromal cells for plasmid-based gene delivery, without the risks associated...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will provide $1,083,078.00 to the University of California, Irvine (UC Irvine) over the period of September 30, 2024 to June 30, 2028. The project aims to examine the role of monocytes and neutrophils in fungal keratitis, a leading cause of corneal blindness and vision loss. Key objectives include investigating neutrophil activation and the effect of monocyte depletion on...

This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) will support research to investigate the role of the opsin protein OPN5 in modulating corneal wound healing through light-dependent mechanisms. The total funding amount is $441,250, with a project period from September 1, 2024 to May 31, 2029.

The key objectives of this project are to: 1) Test the light regimen necessary for accelerating corneal wound healing in mice, 2) Characterize the signal transduction mechanisms within OPN5-expressing corneal cells, and 3) Examine the role of diffusible factors in inducing OPN5 expression and corneal communication. The research will utilize in vivo and ex vivo mouse models, as well as human and non-human primate corneal cell cultures, to explore the translational potential of targeting opsin-mediated pathways to improve corneal wound healing and prevent scarring.

Generated 7/1/25, 2:55 AM